A structure-based approach to a synthetic vaccine for HIV-1

Area of Science:

• Immunology
• Structural Biology
• Vaccine Development

Background:

• Generating neutralizing antibodies requires conformational mimicry of native protein structures.
• Existing methods for creating peptide mimics of protein neutralization sites are limited.
• Conformational compatibility is crucial for antibody-antigen interactions.

Purpose of the Study:

• To develop a method for creating conformational mimics of protein neutralization sites using constrained peptides.
• To identify a cyclic peptide that mimics the V3 loop of HIV-1 gp120.
• To evaluate the immunogenicity and neutralizing capacity of the peptide mimic.

Main Methods:

• Replacing main-chain hydrogen bonds with a hydrazone link to create constrained peptides.
• Screening constrained peptides for binding to neutralizing monoclonal antibodies (MAbs).
• Utilizing Nuclear Magnetic Resonance (NMR) and X-ray crystallography for structural analysis.
• Generating rabbit polyclonal antibodies (PAbs) against the cyclic peptide and testing their binding to gp120 and neutralization of HIV-1.

Main Results:

• A cyclic peptide, loop 5, was identified that binds a V3 MAb with >1000-fold higher affinity than the unconstrained peptide.
• Structural studies indicated loop 5 stabilized beta-turns, mimicking the bound V3 peptide conformation.
• PAbs generated to loop 5, but not the uncyclized peptide, bound HIV-1 gp120.
• Loop 5 PAbs that best mimicked the MAb neutralized HIV-1 with similar potency.

Conclusions:

• Conformation significantly impacts peptide affinity and immunogenicity.
• Constrained peptides can effectively mimic protein neutralization sites.
• This approach holds promise for developing synthetic vaccines, particularly for HIV-1.